What neuroenhancement really improves – and what only works subjectively better. Those who use cognitive performance-enhancing substances particularly frequently. Between Ritalin, Modafinil and coffee, the line between therapy and optimization is blurred. The article classifies prevalences, motivations and risks, explains the mechanisms of action of the most important substance classes and shows why the benefits are often overestimated, with practical tips for medical education in everyday life.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Psychooncology
Communication as the key to therapy adherence
- Cardiology
Minimally invasive – the quiet triumph of modern heart surgery
- Schizophrenia in the early-onset stage
Which antipsychotic should be used for treatment-naive patients?
- Diarrhea in children
The problem of parental expectations
- From symptom to diagnosis
Multilocular cystic renal cell carcinoma (MCRCC)
- Shaping the Future with LLM & Co.
AI in Everyday Clinical Practice: Friend or Foe?
- Ulcerative colitis: current evidence on anti-inflammatory therapies
Remission induction and maintenance with biologics and JAK-i
- Bronchiectasis